BCL2 and breast cancer: CPS-treated BC cells show increased cell size and mesenchymal-like morphology, enhanced expression of vimentin, α5 and β1 integrin subunits and integrin like kinase (ILK) and anti-apoptotic Bcl-2 proteins and downregulation of E-cadherin.